BridgeMD
Prevention study for Diabete Type 2
Official title Peel Family Diabetes Prevention Program
ClinicalTrials.gov ID: NCT07675551
What this study is testing
- What it's testing
- The goal of this Hybrid Type 2 effectiveness-implementation pilot randomized controlled trial is to assess the feasibility and preliminary effectiveness of a community-based wellness coaching intervention to prevent type 2 diabetes (T2D) among South Asian (SA) and Black African and Caribbean (BAC) communities in the Peel region of Ontario, Canada. The study evaluates the impact of the intervention on reducing diabetes risk and related intermediate outcomes, including biomarkers, anthropometric measures, well-being, knowledge, health behaviours, and family-level outcomes in participating family dyads.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 and older. Healthy volunteers may be eligible.
You may be able to join if
- Dyad participants will consist of a self-identified primary family caregiver aged 18 years or older and a youth family member aged 14 to 24 years at...
- Self-identifies as either South Asian or Black, African and Caribbean.
- Lives in the Peel Region (Mississauga, Brampton or Caledon), Ontario, Canada.
- Be 18 years or older and have a youth child aged 14 to 24 years in the household who is willing and consents to participate. AND
- Have no medical diagnosis (self-reported) of diabetes.
You likely can't join if
- for family dyad:
- Do not meet all the criteria above.
- A medical condition or health professional has advised them not to engage in physical activity of any type, or they are following a specific diet.
- Cannot give informed consent to participate voluntarily in the intervention and study.
See the full eligibility criteria
- Dyad participants will consist of a self-identified primary family caregiver aged 18 years or older and a youth family member aged 14 to 24 years at the time of study entry. The primary family caregiver will serve as...
- Self-identifies as either South Asian or Black, African and Caribbean.
- Lives in the Peel Region (Mississauga, Brampton or Caledon), Ontario, Canada.
- Be 18 years or older and have a youth child aged 14 to 24 years in the household who is willing and consents to participate. AND
- Have no medical diagnosis (self-reported) of diabetes.
- Have no medical diagnosis (self-reported) of prediabetes that requires any medical or pharmacological treatment. Have a blood-based sugar greater than or equal to 6.5 measured through the hemoglobin A1c test using a...
- The family dyad (family caregiver and youth) must be proficient in English (reading, writing, and speaking), as English will be the primary language used for the participation eligibility, implementation, delivery, and...
- for family dyad:
- Do not meet all the criteria above.
- A medical condition or health professional has advised them not to engage in physical activity of any type, or they are following a specific diet.
- Cannot give informed consent to participate voluntarily in the intervention and study.
The study team makes the final eligibility decision.
Where it's taking place
- Brampton, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brampton, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.